Schonfeld Strategic Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,900
Closed -$158K 2309
2022
Q4
$158K Sell
14,900
-111,800
-88% -$1.08M ﹤0.01% 2059
2022
Q3
$1.23M Buy
126,700
+40,900
+48% +$542K 0.01% 1138
2022
Q2
$1.24M Buy
85,800
+40,700
+90% +$694K 0.01% 923
2022
Q1
$1.18M Buy
45,100
+26,400
+141% +$749K 0.01% 916
2021
Q4
$740K Buy
18,700
+200
+1% +$9.12K 0.01% 1082
2021
Q3
$925K Buy
18,500
+613
+3% +$33.4K 0.01% 993
2021
Q2
$993K Buy
17,887
+1,587
+10% +$84.5K 0.01% 936
2021
Q1
$762K Buy
16,300
+3,400
+26% +$165K 0.01% 990
2020
Q4
$561K Buy
+12,900
New +$476K 0.01% 1007

Other funds holding HCAT